12 research outputs found
Eosinofilik gastointestinal hastalıklar: Eosinofilik gastro intestinal hastalıkların görülme yaşı küçülüyor mu?
No full text Eozinofilik gastrointestinal hastalıklar gastrointestinal kanalın eozinofilik infiltrasyonu ile karakterizedir. Hastalığın belirtileri etkilenen sindirim segmentine ve sindirim kanalının farklı tabakalarının tutulumuna bağlı olarak değişiklik gösterir. Eozinofilik gastrointestinal hastalıklar, eozinofilik özofajit, eozinofilik gastroenterit ve eozinofilik kolit gibi alt gruplara ayrılır. Eozinofilinin yerleşimine bağlı olarak mukozal, serozal ya da müsküler hastalık olarak gruplamak mümkündür. Mukozal hastalıklar bunların arasında en yaygın olanıdır. Eozinofilik özofajitli hastalar hazımsızlık, kusma, disfaji şikayetleri gösterirken, eozinofilik gastroenterit hastaları karın ağrısı, ishal ve kanlı dışkılama şikayetlerine sahiptir. Eozinofilik kolitli hastalarda ise tipik olarak ishal ve alt kadran ağrısı şikayetlerine rastlanır. Hastalık tipik olarak 3. ve 5. dekatlarda görülmekle birlikte diğer yaş gruplarında da görülebilir. Ana tedavi seçenekleri arasında steroid ve diyet değişikliği vardır. 2011 ile 2012 yılları arasında çocuk gastroenteroloji bölümümüzde 4 hastaya eozinofilik gastrointestinal hastalık tanısı konuldu. Bunlardan 2 tanesi eozinofilik özofajit, 1 tanesi eozinofilik kolit, diğeri ise eozinofilik proktokolit tanısı aldı. Bu makalede eozinofilik gastrointestinal hastalık tanısı almış çocuk hastalarımız güncel çalışmalar ışığında gözden geçirildi. Eosinophilic gastrointestinal disorders constitute a pathology characterized by eosinophilic infiltration of the gastrointestinal tract, the symptoms of which vary depending on the affected digestive segments and the involvement of the different layers of the digestive wall. Eosinophilic gastrointestinal diseases include subcategories such as eosinophilic esophagitis, eosinophilic gastroenteritis and eosinophilic colitis, and depending on the localization of the eosinophilia, it is possible to group them as mucosal, serosal or muscular disease. Mucosal involvement is the most common. Patients with eosinophilic esophagitis suffer from nutrition intolerance, vomiting, and dysphagia; for patients with eosinophilic gastroenteritis, complaints are abdominal pain, diarrhea and blood in stool; and for patients with eosinophilic colitis, they are typically diarrhea and lower quadrant pain. The disease is typically observed in but not limited to the 3rd to 5th decades. The main therapeutic options include steroids and dietary modification. Between 2011 and 2012, 4 patients were diagnosed in our pediatric gastroenterology department. Two were diagnosed with eosinophilic esophagitis, one with eosinophilic colitis and one with eosinophilic proctocolitis. This study aimed to review eosinophilic gastrointestinal diseases in light of the recent studies, referring to children diagnosed with eosinophilic gastrointestinal diseas</p
Cramer Rao Alt Sınırı ile ElektrogastrogramSinyallerinden Özbağlan m ParametrelerininBelirlenmesi
No full textEvaluation Diagnosis Availability of Noninvasive Electrogastrogram Signals for Gastroesophageal Reflux Disease
No full textElectrogastrography (EGG) is obtaining stomach myoelectrical activity non-invasively. Today, reflux is common between disorders of the digestive system. The invasiveness of methods used in the diagnosis of reflux is the biggest disadvantage for diagnosis. In this study, features helping non-invasive diagnosis of reflux disease are intended to obtaine using Electrogastrogram signals. Records were done as hunger and satiety in two ways from patients and healty individuals. Distinctive features was obtained using Singular Spectrum Analysis and Power Spectral Densities. 6 features were extracted from signals. Distinctive offFeautres were examined statistically. Finally, The features have been examined among groups and features that can be successful for classification have been determined
Crohn’xxs disease complicated by granulomatous interstitial nephritis, choroidal neovascularization, and central retinal vein occlusion.
No full textPlasma copeptin levels in the patients with gastrointestinal bleeding.
No full textIntroduction: Gastrointestinal bleeding is a significant cause of morbidity andmortality worldwide. In addition, it constitutes an important part of health expenditures. In this study, we aimed to determine whether there is a relationship between plasma copeptin levels and the etiology, location and severity of gastrointestinal bleeding. Materials and methods: This study was performed prospectively in 104 consecutive patients who were admitted to anemergency department with complaints of bloody vomiting or bloody or black stool. To evaluate the level of biochemical parameters such as Full Blood Count (FBC), serumbiochemistry, bleeding parameters and copeptin, blood samples were obtained at admission. For the copeptin levels, 2 more blood samples were obtained at the 12th and 24th hours after admission. The values obtained were compared using statistical methods. Results: In terms of the etiology of bleeding, the copeptin levels in the patients with peptic ulcer were higher than the levels in patients with other gastrointestinal bleeding. However, the difference was not statistically significant. There were no significant differences among all groups' 0th, 12th and 24th hour levels of copeptin. Discussion: We conclude that copeptin cannot be effectively used as a biochemical parameter in an emergency department to determine the etiology and location of gastrointestinal bleeding. It can, however, be used to make decisions on endoscopy and the hospitalization of patients with suspected gastrointestinal bleeding. (C) 2017 Elsevier Inc. All rights reserved
Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report
No full text[No abstract available
Tracheal and bronchial involvement in colitis ulcerosa – a colo-bronchitic syndrome? A case report and some additional considerations
No full textSystemic involvement is well known in patients with inflammatory bowel diseases (IBD), but there are only few data looking to Crohn’s disease (CD) and ulcerative colitis (UC) separately instead of lumping together both entities to IBD. The frequency of bronchial involvement in UC is not yet exactly analysed but reported to be rare. We asked 100 patients with UC for bronchial complaints, and found in 13 patients a bronchial affection. From reports in the literature it is known that sometimes a bronchial involvement in patients with UC can affect the whole bronchial tree including small bronchi. The involvement of bronchial system in UC is obviously more prominent than previously thought and may fulfil the criteria for a separate syndrome. These relations may have consequences for pathogenetic understanding of UC as well as bronchitis and also consequences for treatment regimes
